Related Experiment Video

Updated: Oct 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering

G Kolovou1

  • 1Onasion Cardiothoracic Surgery Centre, First Cardiology Department, 356 Sygrou Avenue, Kallithea, Athens 176 74, Greece.

Current Medical Research and Opinion
|July 24, 2001
PubMed

Insights

Statins offer vascular benefits beyond lowering LDL cholesterol by acting on blood vessels. Different statins may vary in their effectiveness for preventing vascular disease.

Area of Science:

  • Cardiovascular Pharmacology
  • Lipid Metabolism
  • Vascular Biology

Background:

  • Statins are primarily known for lowering low-density lipoprotein (LDL) cholesterol.
  • Emerging evidence suggests pleiotropic effects of statins beyond lipid-lowering.
  • Vascular events are a major cause of morbidity and mortality.

Framework:

  • This review explores the non-lipid-lowering actions of statins.
  • Focuses on effects on vascular endothelium, smooth muscle, and hemostatic factors.
  • Highlights inter-statin differences in these pleiotropic effects.

Implementation:

  • Statins interact with the vascular endothelium to improve function.
  • They influence vascular smooth muscle cells, affecting proliferation and migration.
  • Statins modulate hemostatic factors, impacting thrombosis risk.

Implications:

  • These pleiotropic effects may contribute to the reduction in vascular events.
  • Variations in these actions suggest differential efficacy among statin medications.
  • Understanding these mechanisms can optimize statin selection for cardiovascular prevention.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...